tirzepatide bmi VisualAbstract: Superior to Semaglutide in Obese Adults Without Diabetes Tirzepatide Injections for Medical Weight

Rosenstock stated in the Regeneron press release: These complete 26-week COURAGE results demonstrate a meaningful opportunity to preserve muscle mass while enhancing fat loss. Also noted: Numerical improvements in metabolic and lipid parameters, secondary and exploratory endpoints, were seen across all treatment groups, including improvements in waist circumference, blood pressure, cholesterol, triglycerides and A1C. Read the full press release:

doi: 10.3389/fendo.2021.767785

Depending on the situation, an additional CPT code may be needed for the injection administration

Coverage can vary widely depending on your specific plan, your diagnosis, and prior authorizations